Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
Authors:
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 34 (13) , 108917
Abstract
No abstract availableKeywords
Funding Information
- American Society of Hematology (1K12NS098482)
- Burroughs Wellcome Fund
- National Institutes of Health (NIAID-KO8AI106953)
- Alex's Lemonade Stand Foundation for Childhood Cancer
- Musella Foundation For Brain Tumor Research and Information
This publication has 61 references indexed in Scilit:
- Human Cytomegalovirus Interleukin-10 Polarizes Monocytes toward a Deactivated M2c Phenotype To Repress Host Immune ResponsesJournal of Virology, 2013
- Origin and differentiation of microgliaFrontiers in Cellular Neuroscience, 2013
- Poor Cerebral Inflammatory Response in eIF2B Knock-In Mice: Implications for the Aetiology of Vanishing White Matter DiseasePLOS ONE, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Neuronal Production of Transthyretin in Human and Murine Alzheimer's Disease: Is It Protective?The Journal of Neuroscience, 2011
- Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug ResistanceCancer Research, 2011
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- The Immunological Genome Project: networks of gene expression in immune cellsNature Immunology, 2008
- User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliabilityNeuroImage, 2006
- Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1+/−p53−/− miceCancer Cell, 2004